New Delhi, July 18 -- The Central Drugs Standard Control Organisation (CDSCO) and state drugs testing laboratories identified 185 drug samples as "Not of Standard Quality" (NSQ) and four as "spurious" during routine regulatory surveillance in June.

These spurious drugs were reported from Bihar, one from New Delhi, and two from Telangana.

The monthly report, published by the CDSCO, highlights India's persistent challenge in maintaining drug integrity across the nation. Of the 185 NSQ drug samples, 55 were flagged by central drugs laboratories, and 130 by state labs.

A senior Delhi government official said that the Delhi drugs control department has down on the sale of fake anti-cholesterol medicines, primarily used for preventing seriou...